Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

HbA₁(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study.

Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR; ADAG Study Group.

Diabetologia. 2011 Jan;54(1):69-72. doi: 10.1007/s00125-010-1918-2. Epub 2010 Oct 1.

2.

Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study.

Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR; ADAG Study Group.

Diabetes. 2010 Jul;59(7):1585-90. doi: 10.2337/db09-1774. Epub 2010 Apr 27.

3.
4.

Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?

Kuenen JC, Borg R, Kuik DJ, Zheng H, Schoenfeld D, Diamant M, Nathan DM, Heine RJ; ADAG Study Group.

Diabetes Care. 2011 Aug;34(8):1843-7. doi: 10.2337/dc10-2217. Epub 2011 Jun 23.

5.

What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in Type 1 diabetes?

Hillman N, Herranz L, Grande C, Vaquero PM, Pallardo LF.

Diabet Med. 2004 May;21(5):468-70.

PMID:
15089792
6.

Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.

Bonora E.

Int J Clin Pract Suppl. 2002 Jul;(129):5-11. Review.

PMID:
12166607
7.

Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept.

Monnier L, Colette C, Owens DR.

Diabetes Metab Res Rev. 2009 Jul;25(5):393-402. doi: 10.1002/dmrr.962. Review.

PMID:
19437415
8.

Strong correlation between glycaemic variability and total glucose exposure in type 2 diabetes is limited to subjects with satisfactory glycaemic control.

Suh S, Joung JY, Jin SM, Kim MY, Bae JC, Park HD, Lee MS, Lee MK, Kim JH.

Diabetes Metab. 2014 Sep;40(4):272-7. doi: 10.1016/j.diabet.2014.01.006. Epub 2014 Mar 11.

PMID:
24630733
10.

A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.

Nauck MA, Haastert B, Trautner C, Müller UA, Nauck MA, Heinemann L; Clinical Trials Study Group of the German Association for the Study of Diabetes (Deutsche Diabetes-Gesellschaft).

Diabetologia. 2014 May;57(5):868-77. doi: 10.1007/s00125-014-3168-1. Epub 2014 Jan 21.

PMID:
24445534
11.

Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study.

Cavalot F, Pagliarino A, Valle M, Di Martino L, Bonomo K, Massucco P, Anfossi G, Trovati M.

Diabetes Care. 2011 Oct;34(10):2237-43. doi: 10.2337/dc10-2414.

12.

Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study.

Cederberg H, Saukkonen T, Laakso M, Jokelainen J, Härkönen P, Timonen M, Keinänen-Kiukaanniemi S, Rajala U.

Diabetes Care. 2010 Sep;33(9):2077-83. doi: 10.2337/dc10-0262. Epub 2010 Jun 23.

13.

Glycaemic instability is an underestimated problem in Type II diabetes.

Praet SF, Manders RJ, Meex RC, Lieverse AG, Stehouwer CD, Kuipers H, Keizer HA, van Loon LJ.

Clin Sci (Lond). 2006 Aug;111(2):119-26.

PMID:
16613586
14.

Postprandial dysmetabolism and large-vessel disease.

Segal P.

Diabetes Nutr Metab. 2002 Dec;15(6 Suppl):3-8. Review.

PMID:
12702001
15.

Relationship between glycated haemoglobin levels and mean glucose levels over time.

Nathan DM, Turgeon H, Regan S.

Diabetologia. 2007 Nov;50(11):2239-44. Epub 2007 Sep 13.

PMID:
17851648
16.

Postprandial glucose - a potential therapeutic target to reduce cardiovascular mortality.

Peter R, Okoseime OE, Rees A, Owens DR.

Curr Vasc Pharmacol. 2009 Jan;7(1):68-74. Review.

PMID:
19149642
17.

Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study.

Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR; ADAG Study Group.

Diabetologia. 2010 Aug;53(8):1608-11. doi: 10.1007/s00125-010-1741-9. Epub 2010 Apr 16.

18.

Empirically establishing blood glucose targets to achieve HbA1c goals.

Wei N, Zheng H, Nathan DM.

Diabetes Care. 2014 Apr;37(4):1048-51. doi: 10.2337/dc13-2173. Epub 2014 Feb 10.

19.

Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements.

Dailey G.

Mayo Clin Proc. 2007 Feb;82(2):229-35; quiz 236. Review.

PMID:
17290732
20.

Which patients should be evaluated for blood glucose variability?

Candido R.

Diabetes Obes Metab. 2013 Sep;15 Suppl 2:9-12. doi: 10.1111/dom.12141. Review.

PMID:
24034514

Supplemental Content

Support Center